Ionis Pharmaceuticals (IONS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 242,077 | 334,605 | 293,993 | 348,889 | 399,266 |
| Marketable Securities | 2,055,579 | 2,148,671 | 1,784,693 | 1,857,327 | 1,931,935 |
| Receivables | 92,188 | 17,928 | 27,259 | 5,140 | 97,778 |
| Inventories | 12,512 | 28,452 | 28,723 | 30,259 | 7,441 |
| Other current assets | 217,934 | 184,194 | 194,715 | 174,060 | 205,433 |
| TOTAL | $2,620,290 | $2,713,850 | $2,329,383 | $2,415,675 | $2,641,853 |
| Non-Current Assets | |||||
| PPE Net | 94,251 | 82,502 | 75,902 | 72,795 | 71,043 |
| Other Non-Current Assets | 289,134 | 284,747 | 285,843 | 275,458 | 277,176 |
| TOTAL | $383,385 | $367,249 | $361,745 | $348,253 | $348,219 |
| Total Assets | $3,003,675 | $3,081,099 | $2,691,128 | $2,763,928 | $2,990,072 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 44,467 | N/A | N/A | 44,332 |
| Accounts payable and accrued liabilities | 42,964 | 9,052 | 9,243 | 13,082 | 26,027 |
| Accrued Expenses | 178,052 | 164,954 | 149,348 | 127,585 | 215,621 |
| Other current liabilities | 9,279 | 10,034 | 8,799 | 9,988 | 8,831 |
| TOTAL | $309,318 | $304,566 | $306,162 | $327,648 | $448,090 |
| Non-Current Liabilities | |||||
| Long Term Debt | 51,924 | N/A | N/A | N/A | 41,836 |
| Deferred Revenues | 78,989 | 76,018 | 94,066 | 130,406 | 151,128 |
| Other Non-Current Liabilities | 1,897,578 | 1,940,289 | 1,932,567 | 1,924,677 | 1,872,276 |
| TOTAL | $2,106,006 | $2,114,065 | $2,121,268 | $2,139,765 | $2,155,296 |
| Total Liabilities | $2,415,324 | $2,418,631 | $2,427,430 | $2,467,413 | $2,603,386 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 158,965 | 157,897 | 146,211 | 145,965 | 145,752 |
| Common Shares | 158 | 158 | 146 | 146 | 144 |
| Retained earnings | -2,249,808 | -2,145,459 | -2,004,979 | -1,938,714 | -1,795,911 |
| Other shareholders' equity | -30,811 | -24,173 | -34,838 | -34,964 | -32,645 |
| TOTAL | $588,351 | $662,468 | $263,698 | $296,515 | $386,686 |
| Total Liabilities And Equity | $3,003,675 | $3,081,099 | $2,691,128 | $2,763,928 | $2,990,072 |